Drug Shortage Report for EPIVAL
Report ID | 153493 |
Drug Identification Number | 00596434 |
Brand name | EPIVAL |
Common or Proper name | DIVALPROEX |
Company Name | BGP PHARMA ULC |
Market Status | MARKETED |
Active Ingredient(s) | VALPROIC ACID |
Strength(s) | 500MG |
Dosage form(s) | TABLET (DELAYED-RELEASE) TABLET (ENTERIC-COATED) |
Route of administration | ORAL ORAL |
Packaging size | 100BT |
ATC code | N03AG |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2022-02-23 |
Actual start date | |
Estimated end date | 2022-03-08 |
Actual end date | 2022-02-08 |
Shortage status | Avoided shortage |
Updated date | 2022-04-18 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2022-04-18 | French | Compare |
v4 | 2022-04-18 | English | Compare |
v3 | 2022-02-24 | English | Compare |
v2 | 2022-01-26 | French | Compare |
v1 | 2022-01-26 | English | Compare |
Showing 1 to 5 of 5